Search Results - "Vanveldhuizen, Peter J"
-
1
A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patients
Published in The Journal of urology (01-09-2011)“…Patients with high risk prostate cancer (prostate specific antigen greater than 20 ng/ml, Gleason score greater than 7, or clinical stage T2b or greater) have…”
Get more information
Journal Article -
2
Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2
Published in Cancer research (Chicago, Ill.) (15-06-2008)“…CCN5/WISP-2 is overexpressed in noninvasive breast cancer cells and tissue samples, whereas its expression is minimal or undetected in invasive conditions…”
Get full text
Journal Article -
3
Leiomyosarcoma of the inferior vena cava: a case report and review of the literature
Published in Cases journal (23-02-2010)“…A 68-year-old white female presented with two years of progressively worsening dyspnea. Echocardiography revealed a large right atrial mass and partial…”
Get full text
Journal Article -
4
2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axis
Published in Molecular cancer therapeutics (01-03-2010)“…The purpose of this study was to evaluate whether 2-methoxyestradiol (2-ME(2)), a promising anticancer agent, modulates Barrett's esophageal adenocarcinoma…”
Get full text
Journal Article -
5
Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue
Published in Oncology reports (01-09-2003)“…Neuropilin-1 (NRP-1), a co-receptor for VEGF165, is overexpressed in various prostate cancer cell lines and in advanced prostate tumors. However, distribution…”
Get more information
Journal Article -
6
Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study
Published in Investigational new drugs (01-01-2004)“…Experimental data, both in vivo and in vitro, suggest that the combination of gemcitabine and cisplatin acts synergistically. Within the Southwest Oncology…”
Get full text
Journal Article -
7
Abstract 5654: Docetaxel followed by temsirolimus suppresses mTOR pathway and can overcome PI3K / AKT over activation mechanism of resistance in lung cancer cell line
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract Background: Mammalian target of rapamycin (mTOR) is a downstream regulatory protein of PI3K/AKT signal transduction pathway. The activation of cell…”
Get full text
Journal Article -
8
Abstract 5160: Tumor cells potentiate mesenchymal stem cells-pericytes transition and requirement through PDGF-BB-NRP-1 axis
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Abstract New blood vessel formation or angiogenic switch is an essential event in the development of solid tumors and their metastatic growth. Tumor blood…”
Get full text
Journal Article -
9
Abstract 3712: 2-Methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and aggressive phenotypes through differential regulation of β-catenin-E-cadherin-axis
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Abstract The purpose of this study was to evaluate whether 2-methoxyestradiol (2-ME2), a promising anticancer agent, modulates Barrett's esophageal…”
Get full text
Journal Article -
10
Biclonal post-transplant B-cell lymphoma: report of a case with two distinct cell populations, XX,t(14;18) and XY,t(11;14)
Published in Cancer genetics and cytogenetics (01-03-2007)“…Abstract Lymphoproliferative disorders are more likely to occur in transplant patients compared to the general population. Typically in these patients,…”
Get full text
Journal Article